Difference between revisions of "I-123 Biomarker Committee"

Revision as of 20:49, 16 November 2018

Co-chairs: John Dickson, PhD; John Seibyl, MD

Secretary: Julie Lisiecki

Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases

Revision as of 19:07, 9 August 2018 (view source) Jlisiecki (talk \| contribs) m (→‎Recent Meetings/Call Summaries) ← Older edit		Revision as of 20:49, 16 November 2018 (view source) Jlisiecki (talk \| contribs) m (→‎Reference Materials) Newer edit →
Line 15:		Line 15:

	==Reference Materials==		==Reference Materials==
		+
		+	*[[Media:QIBA SPECT I-123 BC (11.16.2018).pdf \| QIBA SPECT I-123 Biomarker Committee Presentation]] ''John Seibyl, MD''